Jefferies downgraded Emerson (EMR) to Hold from Buy with an unchanged price target of $145. Emerson has executed on its transformation and already provided its updated outlook, notes the analyst, who sees limited upside in the near-term given the second half guidance ramp.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: